Yong-Jun Huh
Chief Executive Officer bei GREEN CROSS HOLDINGS CORPORATION
Vermögen: 21 Mio $ am 31.03.2024
Profil
Yong-Jun Huh is currently the Co-Chief Executive Officer, Director & VP at Green Cross Holdings Corp.
and a Director at Artiva Biotherapeutics, Inc. He previously worked as a Director at GREEN CROSS WellBeing Corp.
and as an Executive Vice President at Green Cross Corp.
Huh holds an MBA from the University of Wisconsin and an undergraduate degree from Yonsei University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
04.04.2024 | 1 367 454 ( 2,91% ) | 17 Mio $ | 31.03.2024 | |
31.12.2022 | 300 000 ( 1,69% ) | 2 Mio $ | 31.03.2024 | |
GC CELL CORPORATION
0,20% | 30.09.2023 | 31 000 ( 0,20% ) | 967 131 $ | 31.03.2024 |
Aktive Positionen von Yong-Jun Huh
Unternehmen | Position | Beginn |
---|---|---|
GREEN CROSS HOLDINGS CORPORATION | Chief Executive Officer | 01.03.2010 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 01.09.2019 |
Ehemalige bekannte Positionen von Yong-Jun Huh
Unternehmen | Position | Ende |
---|---|---|
GC BIOPHARMA CORP. | Corporate Officer/Principal | - |
GREEN CROSS WELLBEING CORPORATION | Director/Board Member | - |
Ausbildung von Yong-Jun Huh
University of Wisconsin | Masters Business Admin |
Yonsei University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GC BIOPHARMA CORP. | Health Technology |
GREEN CROSS HOLDINGS CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
GREEN CROSS WellBeing Corp. | |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |